RiverVest Venture Fund III (Ohio), L.P.'s Net Worth
$110 Million
Who is RiverVest Venture Fund III (Ohio), L.P.?
RiverVest Venture Fund III (Ohio), L.P. has an estimated net worth of $110 Million. This is based on reported shares across multiple companies, which include Allakos Inc., Reneo Pharmaceuticals, Inc., and SPRUCE BIOSCIENCES, INC..
SEC CIK
RiverVest Venture Fund III (Ohio), L.P.'s CIK is 0001636686
Past Insider Trading and Trends
2020 was RiverVest Venture Fund III (Ohio), L.P.'s most active year for acquiring shares with 3 total transactions. RiverVest Venture Fund III (Ohio), L.P.'s most active month to acquire stocks was the month of March. 2019 was RiverVest Venture Fund III (Ohio), L.P.'s most active year for disposing of shares, totalling 25 transactions. RiverVest Venture Fund III (Ohio), L.P.'s most active month to dispose stocks was the month of May. 2020 saw RiverVest Venture Fund III (Ohio), L.P. paying a total of $3,750,000.00 for 2,148,281 shares, this is the most they've acquired in one year. In 2020 RiverVest Venture Fund III (Ohio), L.P. cashed out on 13,566,666 shares for a total of $81,696,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Allakos Inc. (ALLK) Snapshot price: $1.27
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -15.00% | -862.57K |
—
|
—
| 4.89M |
Jan 4
| |||
Form 4
| -16.67% | -1.15M |
$71.04 | -$81,696,000.00 | 5.75M |
May 12
| |||
Form 4
| -0.56% | -38.73K |
$39.80 | -$1,541,709.60 | 6.9M |
Scheduled
|
Jun 7
| ||
Form 4
| -1.33% | -93.73K |
$39.83 | -$3,733,130.45 | 6.94M |
Scheduled
|
Jun 4 - Jun 6
| ||
Form 4
| -0.76% | -53.91K |
$39.57 | -$2,133,229.25 | 7.03M |
Scheduled
|
May 30 - Jun 3
| ||
Form 4
| -1.24% | -89.32K |
$36.43 | -$3,253,962.30 | 7.09M |
Scheduled
|
Apr 16 - Apr 18
| ||
Form 4
| -1.94% | -142.22K |
$34.49 | -$4,905,661.14 | 7.18M |
Scheduled
|
Feb 15 - Feb 19
| ||
Form 4
| -0.72% | -52.84K |
$42.63 | -$2,252,227.74 | 7.32M |
Scheduled
|
Jan 24
| ||
Form 4
|
∞
| 7.37M |
$18.00 |
—
| 7.37M |
Jul 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Reneo Pharmaceuticals, Inc. (RPHM) Snapshot price: $1.64
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +762.46% | 2.13M |
$15.00 |
—
| 2.41M |
Apr 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SPRUCE BIOSCIENCES, INC. (SPRB) Snapshot price: $4.1
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +113.17% | 2.15M |
$15.00 | $3,750,000.00 | 4.05M |
Oct 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||